Cargando…
Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression
RATIONALE: Quetiapine fumarate is an atypical antipsychotic indicated for various mental disorders, but it has not been studied in Japanese patients with bipolar depression. OBJECTIVES: To evaluate the efficacy and safety of quetiapine XR (extended release) in Japanese patients with bipolar depressi...
Autores principales: | Murasaki, Mitsukuni, Koyama, Tsukasa, Kanba, Shigenobu, Takeuchi, Masahiro, Shimizu, Yuriko, Arita, Eri, Kuroishi, Kentaro, Kamei, Shinya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182597/ https://www.ncbi.nlm.nih.gov/pubmed/30069587 http://dx.doi.org/10.1007/s00213-018-4977-6 |
Ejemplares similares
-
Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression
por: Kanba, Shigenobu, et al.
Publicado: (2019) -
Role of extended release quetiapine in the management of bipolar disorders
por: Al Jurdi, Rayan K, et al.
Publicado: (2010) -
Quetiapine monotherapy for bipolar depression
por: Thase, Michael E
Publicado: (2008) -
Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
por: El-Khalili, Nizar
Publicado: (2012) -
Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL)
por: Simon, Judit, et al.
Publicado: (2018)